Currently out of the existing stock ratings of Ian Somaiya, 50 are a BUY (69.44%), 22 are a HOLD (30.56%).

Ian Somaiya

Work Performance Price Targets & Ratings Chart

Analyst Ian Somaiya works with a stock forecast success ratio of 65.62% fulfilled within 600.4 days on average. Previously, Ian Somaiya worked at BMO, NOMURA.

Ian Somaiya’s has documented 147 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 23-Feb-2018.

Wall Street Analyst Ian Somaiya

Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 8/1/2016. The price target of $304 was fulfilled within 1 day with a profit of $25.98 (9.34%) receiving and performance score of 93.45.

Average potential price target upside

ALXN Alexion Pharmaceuticals AMGN Amgen BIIB Biogen BMRN Biomarin Pharmaceutical CELG Celgene GILD Gilead Sciences INCY yte NBIX Neurocrine Biosciences TTPH Tetraphase Pharmaceuticals ICPT Intercept Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

2 years 10 months 23 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

2 years 10 months 25 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 1 months 24 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 1 months 24 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 2 months 21 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ian Somaiya?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?